Latest Period
Q2 2026
Security Snapshot
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) Institutional Ownership
CUSIP: 00289Y206
13F Institutional Holders and Ownership History from Q2 2022 to Q2 2026
Institutions Reporting
127
Shares (Excl. Options)
39,396,705
Price
$6.18
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.01 par value
- Symbol
- ABEO on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 39,396,705
- Total 13F value
- $243,358,300
- Portfolio coverage rank
- 0%
- Share change
- -131,453
- Value change
- +$2,928,384
- Number of holders
- 127
- Shares outstanding
- 55,555,556
- SEC-reported price per share
- $6.23
- Insider filing price
- $6.23
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value is tracked under CUSIP 00289Y206.
- 127 institutions reported positions in Q2 2026.
- 9 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 107 to 127 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $177,106,604 to $243,358,300.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 127 institutions filings for Q2 2026.
Security key
00289Y206
Latest holder period
Q2 2026
13F holders
127
13D/G owners
9
CIK / CUSIP context first
Open Q2 2026 holders
ABEO full holder history
ABEONA THERAPEUTICS INC. SEC filings
ABEONA THERAPEUTICS INC. company facts
ABEONA THERAPEUTICS INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00289Y206:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
9
Security
ABEO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 10% | 0% | $29,223,271 | +$2,988,881 | 5,775,350 | +11% | Nantahala Capital Management, LLC | 31 Mar 2026 |
| Nantahala Capital Partners Limited Partnership | 5.8% | +15% | $16,868,810 | +$3,619,393 | 3,333,757 | +27% | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 31 Mar 2026 |
| HIRSCHMAN ORIN | 5.4% | $13,893,270 | 3,100,000 | Orin Hirschman | 31 Mar 2026 | |||
| Funicular Funds, LP | 5.3% | $14,916,352 | 3,007,329 | Funicular Funds, LP | 27 Mar 2026 | |||
| BlackRock, Inc. | 5.8% | $16,751,808 | 2,949,262 | BlackRock, Inc. | 30 Jun 2025 | |||
| Kaufman Daniel Louis | 5.2% | $15,306,871 | 2,943,629 | Daniel Kaufman | 26 Mar 2026 | |||
| James Russell Revocable Trust | 5.3% | $18,774,038 | 2,720,875 | James Russell Revocable Trust | 16 Sep 2025 | |||
| INTEGRATED CORE STRATEGIES (US) LLC | 1.7% | $4,292,820 | 809,966 | Millennium Management LLC | 31 Mar 2025 | |||
| MONTANOVA CAPITAL, LLC | 0.9% | -86% | $3,560,000 | -$15,493,120 | 500,000 | -81% | Montanova Capital, LLC | 30 Jun 2026 |
As of 30 Jun 2026, 127 institutional investors reported holding 39,396,705 shares of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO). This represents 71% of the company’s total 55,555,556 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
60%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.2% | 5,136,490 | +2.5% | 1.9% | $31,743,508 |
| BlackRock, Inc. | 6% | 3,352,474 | +4.9% | 0% | $20,718,290 |
| Cable Car Capital, LP | 5.4% | 3,007,329 | 0% | 0.4% | $18,585,293 |
| AIGH Capital Management LLC | 5.4% | 2,987,000 | -3.6% | 1.7% | $18,459,660 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 2,211,433 | +2.2% | 0% | $13,666,656 |
| OneDigital Investment Advisors LLC | 3% | 1,653,024 | 0.09% | $10,215,688 | |
| AWM Investment Company, Inc. | 2.7% | 1,486,130 | +85% | 0.8% | $9,184,283 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 1,261,090 | +4.2% | 0% | $7,795,208 |
| KENNEDY CAPITAL MANAGEMENT LLC | 2.2% | 1,240,071 | -1.9% | 0.14% | $7,663,639 |
| GOLDMAN SACHS GROUP INC | 2.2% | 1,224,806 | +8.3% | 0% | $7,569,301 |
| STATE STREET CORP | 1.9% | 1,040,228 | +8.7% | 0% | $6,428,609 |
| Propel Bio Management, LLC | 1.8% | 983,070 | -26% | 3.2% | $6,075,373 |
| NAN FUNG TRINITY (HK) LTD | 1.7% | 956,770 | 0% | 0.58% | $5,912,839 |
| Diametric Capital, LP | 1.4% | 755,021 | +23% | 0.5% | $4,666,029 |
| J. Goldman & Co LP | 1.2% | 678,173 | +5.9% | 0.15% | $4,191,109 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1.1% | 610,407 | -5.9% | 0.42% | $3,772,315 |
| Rubric Capital Management LP | 1.1% | 608,771 | 0.03% | $3,762,205 | |
| Stonepine Capital Management, LLC | 1% | 557,284 | -25% | 2.6% | $3,444,015 |
| NORTHERN TRUST CORP | 0.99% | 552,630 | +27% | 0% | $3,415,253 |
| CITIGROUP INC | 0.99% | 548,300 | +4.9% | 0% | $3,388,494 |
| NATIONAL BANK OF CANADA /FI/ | 0.9% | 500,000 | 0% | 0% | $3,090,000 |
| MONTANOVA CAPITAL, LLC | 0.9% | 500,000 | -81% | 0.06% | $3,090,000 |
| Knoll Capital Management, LLC | 0.87% | 485,515 | 0% | 1.7% | $3,000,482 |
| PANAGORA ASSET MANAGEMENT INC | 0.74% | 409,075 | +105% | 0.01% | $2,528,084 |
| BANK OF AMERICA CORP /DE/ | 0.67% | 372,406 | -5.5% | 0% | $2,301,470 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
17
Latest
Q2 2026
Rows shown
1-17 of 17
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 39,396,705 | $243,358,300 | +$2,928,384 | $6.18 | 127 |
| 2026 Q1 | 39,532,594 | $177,106,604 | +$150,034 | $4.48 | 107 |
| 2025 Q4 | 38,934,060 | $205,157,125 | +$17,587,157 | $5.27 | 102 |
| 2025 Q3 | 35,587,405 | $187,905,228 | +$3,962,019 | $5.28 | 99 |
| 2025 Q2 | 34,902,859 | $198,249,797 | +$32,047,638 | $5.68 | 95 |
| 2025 Q1 | 29,672,466 | $141,241,182 | -$4,440,489 | $4.76 | 70 |
| 2024 Q4 | 30,594,457 | $170,412,284 | +$10,328,621 | $5.57 | 62 |
| 2024 Q3 | 28,750,213 | $181,703,500 | -$8,991,871 | $6.32 | 54 |
| 2024 Q2 | 30,142,466 | $127,804,658 | +$64,543,759 | $4.24 | 47 |
| 2024 Q1 | 14,448,596 | $104,749,937 | +$6,931,452 | $7.25 | 55 |
| 2023 Q4 | 14,140,688 | $70,843,546 | +$8,490,638 | $5.01 | 48 |
| 2023 Q3 | 12,477,026 | $52,529,560 | +$13,131,838 | $4.21 | 38 |
| 2023 Q2 | 9,392,092 | $37,850,403 | +$7,730,751 | $4.03 | 36 |
| 2023 Q1 | 7,525,889 | $21,222,791 | -$5,713,208 | $2.82 | 33 |
| 2022 Q4 | 7,901,310 | $24,332,329 | +$21,133,266 | $3.08 | 38 |
| 2022 Q3 | 1,039,522 | $3,159,012 | +$3,053,000 | $3.04 | 19 |
| 2022 Q2 | 34,773 | $169,000 | +$169,000 | $4.86 | 1 |